公司概覽
業務類別 Drug Manufacturers - General
業務概覽 Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
公司地址 Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
電話號碼 +1 609 252-4621
傳真號碼 --
公司網頁 https://www.bms.com
員工數量 32500
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Phil Holzer Senior Vice President, Principal Accounting Officer and Controller -- 11/02/2026
Ms. Sandra Leung Executive Vice President and General Counsel -- 18/02/2025
Mr. David V. Elkins Executive Vice President and Chief Financial Officer 美元 1.14M 11/02/2026
Dr. Christopher S. Boerner, PhD Chairman of the Board and Chief Executive Officer 美元 1.59M 25/03/2026
Mr. Adam Lenkowsky Executive Vice President and Chief Commercialization Officer 美元 1.13M 11/02/2026
Dr. Cristian Massacesi, M.D. Executive Vice President, Chief Medical Officer and Head of Development 美元 388.46K 11/02/2026
Mr. Hiroshi Chris Shibutani, M.D. Executive Vice President and Chief Strategy Officer -- 11/02/2026
Mr. Benjamin J. Hickey, M.B.A. President, RayzeBio Organization -- 11/02/2026
Ms. Amanda Ahn Poole Executive Vice President and Chief People Officer -- 11/02/2026
Ms. Cari Gallman Executive Vice President, General Counsel and Chief Policy Officer -- 11/02/2026
Ms. Wendy Short Bartie Executive Vice President, Corporate Affairs -- 11/02/2026
Ms. Lynelle Hoch President, Cell Therapy Organization -- 11/02/2026
Ms. Karin Shanahan Executive Vice President, Chief Supply Chain and Operations -- 11/02/2026
Dr. Robert M. Plenge, M.D.,PhD Executive Vice President, Chief Research Officer and Head of Research -- 11/02/2026
Mr. Gregory Scott Meyers Executive Vice President, Chief Digital Officer and Chief Technology Officer 美元 1.07M 11/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Derica W. Rice Independent Director 25/03/2026
Ms. Phyllis R. Yale Independent Director 25/03/2026
Ms. Paula A. Price Independent Director 25/03/2026
Mr. Peter J. Arduini Independent Director 25/03/2026
Dr. Christopher S. Boerner, PhD Chairman of the Board and Chief Executive Officer 25/03/2026
Dr. Julia A. Haller, M.D. Independent Director 25/03/2026
Mr. Theodore R. Samuels Lead Independent Director 25/03/2026
Dr. Karen H. Vousden, PhD Independent Director 25/03/2026
Dr. Manuel Hidalgo Medina, M.D.,PhD Independent Director 25/03/2026
Mr. Michael R. McMullen Independent Director 25/03/2026
Dr. Deepak L. Bhatt, M.B.A.,M.D.,M.P.H. Independent Director 25/03/2026
 
所屬ETF (更新日期: 02/05/2026 02:40)
代號 名稱 佔比% 持有日期
HTECRobo Global® Hlthcare Tech & Innovt ETF0.001%29/04/2026
RGLORussell Inv Global Equity ETF0.001%25/04/2026
DFTTDF Tactical 30 ETF0.001%29/04/2026
WLDRAffinity World Leaders Equity ETF0.001%29/04/2026
VMAXHartford US Value ETF0.001%29/04/2026
CRTCXtrackers US National Crtcl Techs ETF0.001%29/04/2026
NUDVNuveen ESG Dividend ETF0.001%29/04/2026
PBPInvesco S&P 500 BuyWrite ETF0.001%29/04/2026
UDIVFranklin US Core Dividend Tilt Index ETF0.001%29/04/2026
EQALInvesco Russell 1000 Equal Weight ETF0.001%29/04/2026
KRMAGlobal X Conscious Companies ETF0.001%29/04/2026
AVTMAvantis Total Equity Markets ETF0.001%29/04/2026
GLOFiShares Global Equity Factor ETF0.001%27/04/2026
CSMProShares Large Cap Core Plus0.001%29/04/2026
LCFTouchstone US Large Cap Focused ETF0.001%29/04/2026
QQWZPacer Cash COWZ 100-Nasdaq100RotatorETF0.001%29/04/2026
LDRXSGI Enhanced Market Leaders ETF0.0005%23/04/2026
UPSDAptus Large Cap Upside ETF0.0005%29/04/2026
WBILWBI BullBear Quality 3000 ETF0.0005%29/04/2026
KVLEKraneShares Value Line® Dyn Div Eq ETF0.0005%29/04/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15   16    17    18    19    20    21    22    23    24    25    26  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.